Cardiovascular Medicine

Cardiac Arrhythmias in Patients with COVID-19: A Systematic review and Meta-analysis

1. Omar Hamam
2. Ahmed Goda
3. Moustafa Eldalal
4. Amr Ussama
5. Mostafa Fahmy
6. Karim Elyamany
7. Waleed Ikram
8. Ahmed Mahdy
9. Renu Bhandari
10. Mohammad A. Elbahnasawy
11. Hosam Asal
12. Alexander Egbe

Reviewed by ScreenIT

What is the effect of lockdown upon hospitalisation because of COVID‐19 amongst patients from a heart failure registry?

1. Hani Essa
2. Sophia Brousas
3. Isabel Whybrow‐Hupptaz
4. Thomas Salmon
5. Rajiv Sankaranarayanan

Reviewed by ScreenIT

Cardiac Surgery during the Covid-19 Pandemic: Evidence from the first wave

1. Sotiris Vandoros
2. Nikolaos Schizas
3. Alkis Apostolopoulos
4. Vasilios Patris
5. Mihalis Argiriou

Reviewed by ScreenIT

Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers

1. Annika Lundström
2. Louise Ziegler
3. Sebastian Havervall
4. Ann‐Sofie Rudberg
5. Fien von Meijenfeldt
6. Ton Lisman
7. Nigel Mackman
8. Per Sandén
9. Charlotte Thålin

Reviewed by ScreenIT

Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19

1. Jacob Mok
2. Juan Carlos Malpartida
3. Kimberly O'Dell
4. Joshua Davis
5. Cuilan Gao
6. Harish Manyam

Reviewed by ScreenIT

Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome

1. Oindrila Paul
2. Jian Qin Tao
3. Eric West
4. Leslie Litzky
5. Michael Feldman
6. Kathleen Montone
7. Chamith Rajapakse
8. Christian Bermudez
9. Shampa Chatterjee

Reviewed by ScreenIT

Antiplatelet drugs block platelet activation by VITT patient serum

1. Christopher W. Smith
2. Samantha J. Montague
3. Caroline Kardeby
4. Ying Di
5. Gillian C. Lowe
6. William A. Lester
7. Steve P. Watson
8. Phillip L. R. Nicolson

Reviewed by ScreenIT

Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

1. Kamal Matli
2. Raymond Farah
3. Mario Maalouf
4. Nibal Chamoun
5. Christy Costanian
6. Georges Ghanem

Reviewed by ScreenIT

Leveraging Genetic Data to Elucidate the Relationship Between COVID‐19 and Ischemic Stroke

1. Verena Zuber
2. Alan Cameron
3. Evangelos P. Myserlis
4. Leonardo Bottolo
5. Israel Fernandez‐Cadenas
6. Stephen Burgess
7. Christopher D. Anderson
8. Jesse Dawson
9. Dipender Gill

Reviewed by ScreenIT

Computational modeling identifies embolic stroke of undetermined source patients with potential arrhythmic substrate

1. Savannah F Bifulco
2. Griffin D Scott
3. Sakher Sarairah
4. Zeinab Birjandian
5. Caroline H Roney
6. Steven A Niederer
7. Christian Mahnkopf
8. Peter Kuhnlein
9. Marcel Mitlacher
10. David Tirschwell
11. WT Longstreth
12. Nazem Akoum
13. Patrick M Boyle

• Curated by eLife

  Evaluation Summary:

  In this manuscript, the authors try to answer an important clinical question about the previously observed connection between embolic stroke of undetermined source (ESUS) and atrial fibrillation (AF). Using cutting-edge personalized computational modeling of left atrium from both ESUS and AFib patients, the researchers try to understand why the fibrotic substrate found in both ESUS and AFib patients causes arrhythmia in the latter group but not the former. Their study concludes that the intrinsic capacity to sustain arrhythmias of fibrosis found in ESUS and AFib atrium are identical. The key claims of the manuscript are well supported by the data, and the modeling methodology is largely appropriate.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #2 and Reviewer #3 agreed to share their names with the authors.)

Reviewed by eLife